Menlo Park, CA, United States of America

Mahalakshmi Ramadass

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mahalakshmi Ramadass: Innovator in IL10 Receptor Therapeutics

Introduction

Mahalakshmi Ramadass is an accomplished inventor based in Menlo Park, California. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic molecules.

Latest Patents

Mahalakshmi holds a patent for "IL10 receptor binding molecules and methods of use." This innovative patent includes IL10R binding molecules that specifically bind to IL10Ra and IL10Rb, comprising an IL10Rb sdAb and an IL10Rb VHH antibody. This invention has the potential to advance therapeutic approaches for diseases associated with the IL10 receptor.

Career Highlights

Currently, Mahalakshmi is associated with Synthekine, Inc., where he continues to push the boundaries of biotherapeutics. His work is fundamental to the ongoing research and development at the company, positioning it at the forefront of innovations in immune modulation.

Collaborations

Throughout his career, Mahalakshmi has collaborated with notable professionals in his field, including Robert Kastelein and Deepti Rokkam. These partnerships enhance the quality of research and foster innovation in the development of new therapies.

Conclusion

Mahalakshmi Ramadass's invention of IL10 receptor binding molecules highlights his commitment to advancing medical science. As he continues to work at Synthekine, Inc., his contributions will undoubtedly lead to new insights and breakthroughs in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…